Brigid K. Jensen

Brigid K. Jensen

Auto-generated profile, based on publicly available information

Brigid K. Jensen

Jefferson Weinberg ALS Center, Thomas Jefferson University, Philadelphia, PA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Cell Reports
Verified
Journal Article
Open access
TWThomas Westergard
Thomas Westergard
BJBrigid K. Jensen
Brigid K. Jensen
XWXinmei Wen
Xinmei Wen
JCJingli Cai
Jingli Cai
EKElizabeth Kropf
Elizabeth Kropf
DTDavide Trotti
Davide Trotti
Aberrant hexanucleotide repeat expansions in C9orf72 are the most common genetic change underlying amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). RNA transcripts containing these expansions undergo repeat-associated non-ATG translation (RAN-T) to form five dipeptide repeat proteins (DPRs). DPRs are found as aggregates throughout the CNS of C9orf72-ALS/FTD patients, and some cause degeneration when expressed in vitro in neuronal cultures and in vivo in animal models. The spread of characteristic disease-related proteins drives the progression of pathology in many neurodegenerative diseases. While DPR toxic mechanisms continue to be investigated, the potential for DPRs to spread has yet to be determined. Using different experimental cell culture platforms, including spinal motor neurons derived from induced pluripotent stem cells from C9orf72-ALS patients, we found evidence for cell-to-cell spreading of DPRs via exosome-dependent and exosome-independent pathways, which may be relevant to disease.

14 January 2014 in Journal of NeuroVirology
Verified
Journal Article
Open access
PDF file
CACagla Akay-Espinoza
Cagla Akay-Espinoza
MCMichael Cooper
Michael Cooper
AOAkinleye Odeleye
Akinleye Odeleye
BJBrigid K. Jensen
Brigid K. Jensen
MWMichael G. White
Michael G. White
KJKelly L. Jordan-Sciutto
Kelly L. Jordan-Sciutto
HIV-associated neurocognitive disorder (HAND), characterized by a wide spectrum of behavioral, cognitive, and motor dysfunctions, continues to affect approximately 50 % of HIV(+) patients despite the success of combination antiretroviral drug therapy (cART) in the periphery. Of note, potential toxicity of antiretroviral drugs in the central nervous system (CNS) remains remarkably underexplored and may contribute to the persistence of HAND in the cART era. Previous studies have shown antiretrovirals (ARVs) to be neurotoxic in the peripheral nervous system in vivo and in peripheral neurons in vitro. Alterations in lipid and protein metabolism, mitochondrial damage, and oxidative stress all play a role in peripheral ARV neurotoxicity. We hypothesized that ARVs also induce cellular stresses in the CNS, ultimately leading to neuronal damage and contributing to the changing clinical and pathological picture seen in HIV-positive patients in the cART era. In this report, we show that ARVs are neurotoxic in the CNS in both pigtail macaques and rats in vivo. Furthermore, in vitro, ARVs lead to accumulation of reactive oxygen species (ROS), and ultimately induction of neuronal damage and death. Whereas ARVs alone caused some activation of the endogenous antioxidant response in vitro, augmentation of this response by a fumaric acid ester, monomethyl fumarate (MMF), blocked ARV-induced ROS generation, and neuronal damage/death. These findings implicate oxidative stress as a contributor to the underlying mechanisms of ARV-induced neurotoxicity and will provide an access point for adjunctive therapies to complement ARV therapy and reduce neurotoxicity in this patient population.

6 July 2016 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
HMHubert Monnerie
Hubert Monnerie
MRMicah Romer
Micah Romer
BJBrigid K. Jensen
Brigid K. Jensen
JMJohn S. Millar
John S. Millar
KJKelly L. Jordan‐Sciutto
Kelly L. Jordan‐Sciutto
JGJudith B. Grinspan
Judith B. Grinspan
The formation of the myelin membrane of the oligodendrocyte in the CNS is a fundamental process requiring the coordinated synthesis of many different components. The myelin membrane is particularly rich in lipids, however, the regulation of this lipid synthesis is not understood. In other cell types, including Schwann cells, the myelin‐forming cells of the PNS, lipid synthesis is tightly regulated by the sterol regulatory element‐binding protein (SREBP) family of transcription factors, but this has not been previously shown in oligodendrocytes. We investigated SREBPs' role during oligodendrocyte differentiation in vitro. Both SREBP‐1 and SREBP‐2 were expressed in oligodendrocyte precursor cells and differentiating oligodendrocytes. Using the selective site‐1 protease (S1P) inhibitor PF‐429242, which inhibits the cleavage of SREBP precursor forms into mature forms, we found that preventing SREBP processing inhibited process growth and reduced the expression level of myelin basic protein, a major component of myelin. Further, process extension deficits could be rescued by the addition of exogenous cholesterol. Blocking SREBP processing reduced mRNA transcription and protein levels of SREBP target genes involved in both the fatty acid and the cholesterol synthetic pathways. Furthermore, de novo levels and total levels of cholesterol synthesis were greatly diminished when SREBP processing was inhibited. Together these results indicate that SREBPs are important regulators of oligodendrocyte maturation and that perturbation of their activity may affect myelin formation and integrity. image Cover Image for this issue: doi: 10.1111/jnc.13781.

1 November 2015 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
BJBrigid K. Jensen
Brigid K. Jensen
HMHubert Monnerie
Hubert Monnerie
MMMaggie V. Mannell
Maggie V. Mannell
PGPatrick J. Gannon
Patrick J. Gannon
CACagla Akay-Espinoza
Cagla Akay-Espinoza
JGJudith B. Grinspan
Judith B. Grinspan
Despite effective viral suppression through combined antiretroviral therapy (cART), approximately half of HIV-positive individuals have HIV-associated

29 April 2020 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
BJBrigid K Jensen
Brigid K Jensen
MSMartin H Schuldi
Martin H Schuldi
KMKevin McAvoy
Kevin McAvoy
KRKatelyn A Russell
Katelyn A Russell
ABAshley Boehringer
Ashley Boehringer
DTDavide Trotti
Davide Trotti
The most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is an intronic hexanucleotide repeat expansion in the C9orf72 gene. In disease, RNA transcripts containing this expanded region undergo repeat‐associated non‐AUG translation to produce dipeptide repeat proteins (DPRs), which are detected in brain and spinal cord of patients and are neurotoxic both in vitro and in vivo paradigms. We reveal here a novel pathogenic mechanism for the most abundantly detected DPR in ALS/FTD autopsy tissues, poly‐glycine‐alanine (GA). Previously, we showed motor dysfunction in a GA mouse model without loss of motor neurons. Here, we demonstrate that mobile GA aggregates are present within neurites, evoke a reduction in synaptic vesicle‐associated protein 2 (SV2), and alter Ca 2+ influx and synaptic vesicle release. These phenotypes could be corrected by restoring SV2 levels. In GA mice, loss of SV2 was observed without reduction of motor neuron number. Notably, reduction in SV2 was seen in cortical and motor neurons derived from patient induced pluripotent stem cell lines, suggesting synaptic alterations also occur in patients.

1 December 2019 in Brain Research
Verified
Journal Article
Closed access
BJBrigid K. Jensen
Brigid K. Jensen
LRLindsay M. Roth
Lindsay M. Roth
JGJudith B. Grinspan
Judith B. Grinspan
KJKelly L. Jordan-Sciutto
Kelly L. Jordan-Sciutto